While TNF-α promotes inflammation and may exacerbate disease progression, TGF-β’s role appears to be more context-dependent, potentially exhibiting tumor-suppressive effects that are overridden in the leukemic microenvironment. This evidence concerns the gene TGFB1 and neoplasm.